➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Colorcon
Medtronic
Moodys
Mallinckrodt
McKesson
Baxter

Last Updated: June 3, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR QUININE SULFATE

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Quinine Sulfate

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00000706 Influence of Probenecid and Quinine on the Pharmacokinetics of Azidothymidine Completed National Institute of Allergy and Infectious Diseases (NIAID) N/A 1969-12-31 Part I studies the effect of quinine on how zidovudine (AZT) is used by the body and eliminated through the kidneys in HIV infected patients. Part II studies the effect of probenecid and quinine on the same aspects. Because AZT leaves the bloodstream quickly, patients must take the drug frequently to keep adequate amounts in their bodies. Probenecid and quinine may slow down the rate at which AZT leaves the body. Therefore, taking these drugs along with AZT may reduce the amount of AZT needed for treatment.
NCT00726414 A Relative Bioavailability Study of Quinine Sulfate Capsules 324mg Completed Mutual Pharmaceutical Company, Inc. Phase 1 2005-12-01 The purpose of this study is to evaluate and compare the relative bioavailability of Quinine Sulfate capsules following a single, oral dose in healthy volunteers under fasting and fed conditions.
NCT00726895 A Dose Proportionality Study of Quinine Sulfate Capsules Under Fasting Conditions Completed Mutual Pharmaceutical Company, Inc. Phase 1 2004-05-01 The purpose of this study is to evaluate and compare the dose proportionality of 324 mg Quinine Sulfate capsules following a single oral dose (1 x 324 mg capsules versus 2 x 324 mg capsules) in healthy adult volunteers when administered under fasting conditions.
NCT00727272 A Relative Bioavailability Study of Quinine Sulfate Capsules Under Fasting and Fed Conditions Completed Mutual Pharmaceutical Company, Inc. Phase 1 2004-02-01 The purpose of this study is to evaluate and compare the relative bioavailability of Quinine Sulfate 324 mg capsules, manufactured by the Mutual Pharmaceutical Company, to Quinine Sulphate 300 mg tablets, manufactured by the Government Pharmaceutical Organization, Bangkok Metropolis, Thailand, after single oral dose administration under fasting conditions. An additional purpose of this study is to evaluate the effect of food on the Mutual Pharmaceutical Company product.
NCT00779259 Drug - Drug Interaction Study Between Quinine Sulfate and Theophylline Completed Mutual Pharmaceutical Company, Inc. Phase 1 2007-08-01 In a prior in vitro study using human hepatocytes quinine was shown to induce the activity of Cytochrome p450 CYP 1A2. The present study will evaluate the extent to which quinine sulfate-related induction of this enzyme effects the pharmacokinetics of theophylline, a sensitive probe drug for the activity of CYP 1A2. It will also evaluate the effect of single-dose theophylline on the pharmacokinetics of steady-state quinine sulfate.
NCT00785213 Drug-Drug Interaction Study Between Quinine Sulfate and Rosiglitazone Completed Cetero Research, San Antonio Phase 1 2008-09-01 Rosiglitazone is predominantly metabolized by cytochrome P450 (CYP) 2C8. Quinine sulfate is an inhibitor of CYP 2C8. This study will evaluate the effect of multiple doses of quinine sulfate at steady-state on the pharmacokinetics of single-dose rosiglitazone in healthy adult subjects.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Quinine Sulfate

Condition Name

Condition Name for Quinine Sulfate
Intervention Trials
Healthy 8
HIV Infections 1
Hemorrhoids, Internal 1
Sinusitis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Quinine Sulfate
Intervention Trials
Renal Insufficiency 1
Rhinitis 1
HIV Infections 1
Spasm 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Quinine Sulfate

Trials by Country

Trials by Country for Quinine Sulfate
Location Trials
United States 7
Portugal 1
Switzerland 1
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Quinine Sulfate
Location Trials
North Dakota 2
Pennsylvania 1
Florida 1
Arizona 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Quinine Sulfate

Clinical Trial Phase

Clinical Trial Phase for Quinine Sulfate
Clinical Trial Phase Trials
Phase 2 1
Phase 1/Phase 2 1
Phase 1 9
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Quinine Sulfate
Clinical Trial Phase Trials
Completed 10
Recruiting 2
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Quinine Sulfate

Sponsor Name

Sponsor Name for Quinine Sulfate
Sponsor Trials
Mutual Pharmaceutical Company, Inc. 9
National Institute of Allergy and Infectious Diseases (NIAID) 1
Universidade do Porto 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Quinine Sulfate
Sponsor Trials
Industry 9
Other 5
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
McKesson
Merck
Mallinckrodt
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.